Your browser doesn't support javascript.
loading
Trelagliptin ameliorates oxygen-glucose deprivation/reperfusion (OGD/R)-induced mitochondrial dysfunction and metabolic disturbance of endothelial cells.
Zhang, Yatong; Li, Chao; Pei, Yifang; Zheng, Li; Sun, Xuelin; Zhao, Zinan; Wang, Shuanghu.
Afiliação
  • Zhang Y; Department of pharmacy, Beijing Hospital; National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, 100730, China.
  • Li C; Department of pharmacy, Beijing Hospital; National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, 100730, China.
  • Pei Y; Department of pharmacy, Beijing Hospital; National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, 100730, China.
  • Zheng L; Department of Pharmacy, China Aerospace Science and Industry Corporation 731 Hospital, Beijing, 100074, China.
  • Sun X; Department of pharmacy, Beijing Hospital; National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, 100730, China.
  • Zhao Z; Department of pharmacy, Beijing Hospital; National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, 100730, China.
  • Wang S; The Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People's Hospital of Lishui, #15 Dazhong Street, Liandu District, Lishui City, 323000, Zhejiang, China. wangsh026@126.com.
Hum Cell ; 34(6): 1717-1726, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34435315
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uracila / Doenças Mitocondriais / Células Endoteliais / Inibidores da Dipeptidil Peptidase IV / Hipóxia / Mitocôndrias Limite: Humans Idioma: En Revista: Hum Cell Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uracila / Doenças Mitocondriais / Células Endoteliais / Inibidores da Dipeptidil Peptidase IV / Hipóxia / Mitocôndrias Limite: Humans Idioma: En Revista: Hum Cell Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Japão